Tech Company Financing Transactions
Spiden Funding Round
Spiden closed a $15 million venture capital round on 1/31/2024. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/31/2024
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to finalize its initial, now 6-year long phase of R&D, aimed at cracking complete calibration-free monitoring, as well as securing a pathway to miniaturization of its portable product to a wearable format.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
Talstrasse 35
Pfäffikon, 8808
Switzerland
Pfäffikon, 8808
Switzerland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
A revolutionary leap forward in the well-being of humanity through real-time continuous biomarker and drug monitoring. Starting with glucose, we aim to reach the holy grail of continuous, non-invasive, and medical grade multi-biomarker monitoring, in a next generation wearable, providing us with data to live longer, healthier lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leo Grünstein
Chief Operating Officer
Daniel Thürig
Chief Scientific Officer
Adler Perotte
Chief Technical Officer
Chester Chipperfield
Chief Technical Officer
Bernd Wittner
Co-Founder
Övu¨nç Okyay
VP - Product Management
Ismene Grohmann
Browse more venture capital transactions:
Prev: 1/31/2024: BlokID venture capital transaction
Next: 1/31/2024: Halia Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs